Shopping Cart 0
Cart Subtotal
USD 0

Pangaea Biotech SL - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250

Details

Summary

Pangaea Biotech SL (Pangaea) is a provider of molecular diagnostics and research and development services for cancer treatment. The company discovers and develops gene signatures and prognostic markers. Its services include molecular diagnosis, in vitro drug testing, clinical trials, biomarker discovery, drug development, dx platform validation, in licensing and out licensing services. Pangaea's molecular diagnosis services comprise gene amplification and translocation testing; mutation analysis in tumor tissue and blood, immuno-histochemistry and gene expression programs. The company improves clinical development process through discovery of novel markers and validation in tumor samples and cell lines. It operates through pharmaceutical, diagnostics and biotech companies for anti-cancer drug development. Pangaea is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Pangaea Biotech SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Pangaea Biotech SL Company Overview 4

Pangaea Biotech SL Company Snapshot 4

Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4

Pangaea Biotech SL-Pipeline Analysis Overview 6

Pangaea Biotech SL-Key Facts 6

Pangaea Biotech SL-Major Products and Services 7

Pangaea Biotech SL Pipeline Products by Development Stage 8

Pangaea Biotech SL Pipeline Products Overview 10

BRCA1 RNA Test 10

BRCA1 RNA Test Product Overview 10

EGFR Enrichment Test 11

EGFR Enrichment Test Product Overview 11

EGFR Serum Mutation Test 12

EGFR Serum Mutation Test Product Overview 12

Genetic Mutation Test-Breast Cancer 13

Genetic Mutation Test-Breast Cancer Product Overview 13

Genetic Mutation Test-Colon Cancer 14

Genetic Mutation Test-Colon Cancer Product Overview 14

Genetic Mutation Test-Melanoma 15

Genetic Mutation Test-Melanoma Product Overview 15

Genetic Mutation Test-Pancreatic Cancer 16

Genetic Mutation Test-Pancreatic Cancer Product Overview 16

Pangaea Biotech SL-Key Competitors 17

Pangaea Biotech SL-Key Employees 18

Pangaea Biotech SL-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Pangaea Biotech SL, Recent Developments 20

Feb 02, 2015: LABCO and PANGAEA, led by Dr Rafael Rosell, join forces to launch a non-invasive test for monitoring cancer treatment 20

Appendix 21

Methodology 21

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Pangaea Biotech SL Pipeline Products by Equipment Type 5

Pangaea Biotech SL Pipeline Products by Development Stage 8


List Of Table

List of Tables

Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4

Pangaea Biotech SL Pipeline Products by Equipment Type 5

Pangaea Biotech SL Pipeline Products by Indication 5

Pangaea Biotech SL, Key Facts 6

Pangaea Biotech SL, Major Products and Services 7

Pangaea Biotech SL Number of Pipeline Products by Development Stage 8

Pangaea Biotech SL Pipeline Products Summary by Development Stage 9

BRCA1 RNA Test-Product Status 10

BRCA1 RNA Test-Product Description 10

EGFR Enrichment Test-Product Status 11

EGFR Enrichment Test-Product Description 11

EGFR Serum Mutation Test-Product Status 12

EGFR Serum Mutation Test-Product Description 12

Genetic Mutation Test-Breast Cancer-Product Status 13

Genetic Mutation Test-Breast Cancer-Product Description 13

Genetic Mutation Test-Colon Cancer-Product Status 14

Genetic Mutation Test-Colon Cancer-Product Description 14

Genetic Mutation Test-Melanoma-Product Status 15

Genetic Mutation Test-Melanoma-Product Description 15

Genetic Mutation Test-Pancreatic Cancer-Product Status 16

Genetic Mutation Test-Pancreatic Cancer-Product Description 16

Pangaea Biotech SL, Key Employees 18

Glossary 23

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Pangaea Biotech SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

PharmaModelling SL

Oryzon Genomics SA

Intelligent Pharma SL

Anaxomics Biotech SL

Company Profile

Company Profile Title

Summary

Pangaea Biotech SL (Pangaea) is a provider of molecular diagnostics and research and development services for cancer treatment. The company discovers and develops gene signatures and prognostic markers. Its services include molecular diagnosis, in vitro drug testing, clinical trials, biomarker discovery, drug development, dx platform validation, in licensing and out licensing services. Pangaea's molecular diagnosis services comprise gene amplification and translocation testing; mutation analysis in tumor tissue and blood, immuno-histochemistry and gene expression programs. The company improves clinical development process through discovery of novel markers and validation in tumor samples and cell lines. It operates through pharmaceutical, diagnostics and biotech companies for anti-cancer drug development. Pangaea is headquartered in Barcelona, Spain.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Pangaea Biotech SL

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Pangaea Biotech SL Company Overview 4

Pangaea Biotech SL Company Snapshot 4

Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4

Pangaea Biotech SL-Pipeline Analysis Overview 6

Pangaea Biotech SL-Key Facts 6

Pangaea Biotech SL-Major Products and Services 7

Pangaea Biotech SL Pipeline Products by Development Stage 8

Pangaea Biotech SL Pipeline Products Overview 10

BRCA1 RNA Test 10

BRCA1 RNA Test Product Overview 10

EGFR Enrichment Test 11

EGFR Enrichment Test Product Overview 11

EGFR Serum Mutation Test 12

EGFR Serum Mutation Test Product Overview 12

Genetic Mutation Test-Breast Cancer 13

Genetic Mutation Test-Breast Cancer Product Overview 13

Genetic Mutation Test-Colon Cancer 14

Genetic Mutation Test-Colon Cancer Product Overview 14

Genetic Mutation Test-Melanoma 15

Genetic Mutation Test-Melanoma Product Overview 15

Genetic Mutation Test-Pancreatic Cancer 16

Genetic Mutation Test-Pancreatic Cancer Product Overview 16

Pangaea Biotech SL-Key Competitors 17

Pangaea Biotech SL-Key Employees 18

Pangaea Biotech SL-Locations And Subsidiaries 19

Head Office 19

Recent Developments 20

Pangaea Biotech SL, Recent Developments 20

Feb 02, 2015: LABCO and PANGAEA, led by Dr Rafael Rosell, join forces to launch a non-invasive test for monitoring cancer treatment 20

Appendix 21

Methodology 21

About GlobalData 24

Contact Us 24

Disclaimer 24


List Of Figure

List of Figures

Pangaea Biotech SL Pipeline Products by Equipment Type 5

Pangaea Biotech SL Pipeline Products by Development Stage 8


List Of Table

List of Tables

Pangaea Biotech SL Pipeline Products and Ongoing Clinical Trials Overview 4

Pangaea Biotech SL Pipeline Products by Equipment Type 5

Pangaea Biotech SL Pipeline Products by Indication 5

Pangaea Biotech SL, Key Facts 6

Pangaea Biotech SL, Major Products and Services 7

Pangaea Biotech SL Number of Pipeline Products by Development Stage 8

Pangaea Biotech SL Pipeline Products Summary by Development Stage 9

BRCA1 RNA Test-Product Status 10

BRCA1 RNA Test-Product Description 10

EGFR Enrichment Test-Product Status 11

EGFR Enrichment Test-Product Description 11

EGFR Serum Mutation Test-Product Status 12

EGFR Serum Mutation Test-Product Description 12

Genetic Mutation Test-Breast Cancer-Product Status 13

Genetic Mutation Test-Breast Cancer-Product Description 13

Genetic Mutation Test-Colon Cancer-Product Status 14

Genetic Mutation Test-Colon Cancer-Product Description 14

Genetic Mutation Test-Melanoma-Product Status 15

Genetic Mutation Test-Melanoma-Product Description 15

Genetic Mutation Test-Pancreatic Cancer-Product Status 16

Genetic Mutation Test-Pancreatic Cancer-Product Description 16

Pangaea Biotech SL, Key Employees 18

Glossary 23

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Pangaea Biotech SL, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

PharmaModelling SL

Oryzon Genomics SA

Intelligent Pharma SL

Anaxomics Biotech SL